Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 106,717 | 92,895 | 101,222 | 8,943 | 33,587 |
| Marketable Securities | 59,753 | 86,387 | 90,346 | 90,223 | 70,113 |
| TOTAL | $169,512 | $180,556 | $192,350 | $99,359 | $103,977 |
| Non-Current Assets | |||||
| PPE Net | 2,374 | 1,769 | 1,192 | 1,409 | 1,676 |
| TOTAL | $2,374 | $1,769 | $1,192 | $1,409 | $1,676 |
| Total Assets | $171,886 | $182,325 | $193,542 | $100,768 | $105,653 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 863 | 228 | 725 | 1,054 | 958 |
| Accrued Expenses | 4,105 | 2,966 | 3,881 | 776 | 672 |
| TOTAL | $4,968 | $3,194 | $4,606 | $1,830 | $1,630 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,968 | $3,194 | $4,606 | $1,830 | $1,630 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,311 | 62,087 | 58,437 | 48,552 | 48,568 |
| Common Shares | 3 | 248 | 248 | 247 | 2 |
| Retained earnings | -157,116 | -141,428 | -122,669 | -111,106 | -104,222 |
| Other shareholders' equity | 29 | 163 | 78 | 68 | 48 |
| TOTAL | $166,918 | $179,131 | $188,936 | $98,938 | $104,023 |
| Total Liabilities And Equity | $171,886 | $182,325 | $193,542 | $100,768 | $105,653 |